Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard M Stone

Showing results (161-170 of 420) with videos related to

Pageof 42
Sort By:
Oncotarget|February 14, 2018
Discovery and functional implications of a miR-29b-1/miR-29a cluster polymorphism in acute myeloid leukemiaApollinaire Ngankeu, Parvathi Ranganathan, Violaine Havelange, et al.
JCO Oncology Practice|April 14, 2023
Outcomes of Older Adults With AML Treated in Community Versus Academic Centers: An Analysis of Alliance TrialsVijaya Raj Bhatt, Angela M Ulrich, Geoffrey L Uy, et al.
Genes & Cancer|December 25, 2012
The STAT5 Inhibitor Pimozide Displays Efficacy in Models of Acute Myelogenous Leukemia Driven by FLT3 MutationsErik A Nelson, Sarah R Walker, Michael Xiang, et al.
Blood Advances|July 11, 2023
Effect of BMI on toxicities and survival among adolescents and young adults treated on DFCI Consortium ALL trialsShai Shimony, Yael Flamand, Yannis K Valtis, et al.
Blood|September 4, 2004
Patients with acute myeloid leukemia and an activating mutation in FLT3 respond to a small-molecule FLT3 tyrosine kinase inhibitor, PKC412Richard M Stone, Daniel J DeAngelo, Virginia Klimek, et al.
Leukemia & Lymphoma|February 7, 2020
Wide variation in use and interpretation of gene mutation profiling panels among health care providers of patients with myelodysplastic syndromes: results of a large web-based surveyAlexander B Pine, Nora Chokr, Maximilian Stahl, et al.
Leukemia|August 8, 2020
Comparison of clinical and molecular characteristics of patients with acute myeloid leukemia and either TP73 or TP53 mutationsAlice S Mims, Jessica Kohlschmidt, Ann-Kathrin Eisfeld, et al.
Leukemia Research|September 15, 2022
Efficacy of FLT3 and IDH1/2 inhibitors in patients with acute myeloid leukemia previously treated with venetoclaxJan Philipp Bewersdorf, Rory M Shallis, Andriy Derkach, et al.
Cancer Research|October 28, 2016
Mutational Landscape and Gene Expression Patterns in Adult Acute Myeloid Leukemias with Monosomy 7 as a Sole AbnormalityAnn-Kathrin Eisfeld, Jessica Kohlschmidt, Krzysztof Mrózek, et al.
American Journal of Hematology|June 18, 2011
Comparison of autologous stem cell transplantation versus consolidation chemotherapy for patients with cytogenetically normal acute myeloid leukemia (CN-AML) and FLT3ITDHarshabad Singh, Lillian L Werner, Salma Asali, et al.
Pageof 42

Showing results (161-170 of 420) with videos related to

Sort By:
Pageof 42
Oncotarget|February 14, 2018
Discovery and functional implications of a miR-29b-1/miR-29a cluster polymorphism in acute myeloid leukemiaApollinaire Ngankeu, Parvathi Ranganathan, Violaine Havelange, et al.
JCO Oncology Practice|April 14, 2023
Outcomes of Older Adults With AML Treated in Community Versus Academic Centers: An Analysis of Alliance TrialsVijaya Raj Bhatt, Angela M Ulrich, Geoffrey L Uy, et al.
Genes & Cancer|December 25, 2012
The STAT5 Inhibitor Pimozide Displays Efficacy in Models of Acute Myelogenous Leukemia Driven by FLT3 MutationsErik A Nelson, Sarah R Walker, Michael Xiang, et al.
Blood Advances|July 11, 2023
Effect of BMI on toxicities and survival among adolescents and young adults treated on DFCI Consortium ALL trialsShai Shimony, Yael Flamand, Yannis K Valtis, et al.
Blood|September 4, 2004
Patients with acute myeloid leukemia and an activating mutation in FLT3 respond to a small-molecule FLT3 tyrosine kinase inhibitor, PKC412Richard M Stone, Daniel J DeAngelo, Virginia Klimek, et al.
Leukemia & Lymphoma|February 7, 2020
Wide variation in use and interpretation of gene mutation profiling panels among health care providers of patients with myelodysplastic syndromes: results of a large web-based surveyAlexander B Pine, Nora Chokr, Maximilian Stahl, et al.
Leukemia|August 8, 2020
Comparison of clinical and molecular characteristics of patients with acute myeloid leukemia and either TP73 or TP53 mutationsAlice S Mims, Jessica Kohlschmidt, Ann-Kathrin Eisfeld, et al.
Leukemia Research|September 15, 2022
Efficacy of FLT3 and IDH1/2 inhibitors in patients with acute myeloid leukemia previously treated with venetoclaxJan Philipp Bewersdorf, Rory M Shallis, Andriy Derkach, et al.
Cancer Research|October 28, 2016
Mutational Landscape and Gene Expression Patterns in Adult Acute Myeloid Leukemias with Monosomy 7 as a Sole AbnormalityAnn-Kathrin Eisfeld, Jessica Kohlschmidt, Krzysztof Mrózek, et al.
American Journal of Hematology|June 18, 2011
Comparison of autologous stem cell transplantation versus consolidation chemotherapy for patients with cytogenetically normal acute myeloid leukemia (CN-AML) and FLT3ITDHarshabad Singh, Lillian L Werner, Salma Asali, et al.
Pageof 42